Fabry disease phenotyping in women from the complete Romanian cohort - time for early diagnostic awareness.
Adriana MursăSebastian MilitaruElena RusuSebastian OnciulGabriela NeculaeRobert AdamLucia CiobotaruVlad StefănescuAdriana DulămeaViorica RădoiBogdan Alexandru PopescuGener IsmailRuxandra JurcuţPublished in: Romanian journal of internal medicine = Revue roumaine de medecine interne (2024)
Fabry disease (FD) is an X-linked rare disorder caused by mutations in the GLA gene. Women with FD have been less enrolled in studies and less treated compared with men. The aim of the present study is to describe the complete phenotype of the women cohort with FD diagnosed and evaluated in Romania and compare it to the male population. This study included all consecutive patients diagnosed with FD referred to the Expert Center for Rare Genetic Cardiovascular Diseases between 2014-2023 which included 73 consecutive Romanian FD patients: 41 women (56.2%) and 32 men (43.8%) from 33 unrelated families. Women with FD were diagnosed later and had a later symptom onset. Comparing with men, women were less often symptomatic, but with similar symptom severity. They had similar ophthalmologic and ENT involvement, but less angiokeratomas. Both women and men had similar heart failure symptoms, which were usually mild to moderate, with no difference between the age of developing of the heart failure symptoms. There were also similar rates of acroparesthesia and stroke between sexes, but women presented less renal involvement, with less requirement for renal transplant. This study demonstrates that women with Fabry disease are not just carriers of the disease, they can present symptoms as severe as men, and they have less or later access to pathogenic therapy. Further studies with more female participations are needed to better understand the burden of Fabry disease in women.
Keyphrases
- polycystic ovary syndrome
- heart failure
- cervical cancer screening
- cardiovascular disease
- end stage renal disease
- atrial fibrillation
- middle aged
- replacement therapy
- insulin resistance
- adipose tissue
- copy number
- brain injury
- hypertrophic cardiomyopathy
- mesenchymal stem cells
- clinical practice
- sleep quality
- patient reported outcomes
- transcription factor
- blood brain barrier
- early onset
- smoking cessation
- coronary artery disease
- acute heart failure
- drug induced
- skeletal muscle
- case control
- genome wide identification